Динамика естественного отбора опухолевых клеток in vivo при локальном росте и диссеминации
Диссертация
Полученные данные свидетельствовали о возможности использовать НР-фенотип в качестве маркера определенной, относительно ранней (предметастатической) стадии опухолевой прогрессии. Исключительные селективные преимущества опухолевых клеток, связанные с приобретением ими HP-фенотипа, т. е. способности защищаться против эффекторов системы естественной резистентности, обязательный характер приобретения… Читать ещё >
Список литературы
- Дейчман Г. И. (1979) Современные концепции иммунологических взаимоотношений опухоли и организма. Глава в кн. «Опухолевый рост как проблема биологии развития», Изд. «Наука», Москва, 208−230
- Дейчман Г. И. (2000а) Естественный отбор и ранние изменения фенотипа опухолевых клеток in vivo: приобретение механизмов защиты. Биохимия, 65 (1), 92−111
- Дейчман Г. И. (20 006) Опухолевые антигены и противоопухолевый иммунитет. «Канцерогенез». Коллективная монография. Изд. Научный мир. 308−330
- Дейчман Г. И., Вендров Е. Л. (1985) Резистентность опухолевых клеток к перекиси водорода как фактор отбора in vivo высокоместатических клеточных вариантов. ДАН СССР, 284, 6, 1510−1513
- Дейчман Г. И., Кашкина Л. М., Матвеева В. А., Дьякова H.A., Уварова Э. Н. (2001) Фенотипические различия между трансформированными in vitro и опухолевыми клетками: ранние стадии естественного отбора in vivo Вестник РОНЦ (юбилейный выпуск), 3, 16−24
- Дейчман Г. И., Капшева Е. А. (1987) Чувствительность к перекиси водорода и выживаемость in vivo клеток сирийского хомяка, трансформированных in vitro вирусом саркомы Рауса. ДАН СССР, 292, 2, 473−476
- Дейчман Г. И., Ключарёва Т. Е., Кашкина Л. М., Матвеева В. А., Теплова М. А., Вендров Е. Л. и Земцова В.А. (1981) Подавляющая резистентность активность трансформированных клеток сирийского хомяка и их способность к метастазированию. БЭБ и М, 11, 596−598
- Кашкина Л.М., Прилуцкая М. О., Горожанская Э. Г., Михаевич О. Д., Кушлинский Н. Е. и Дейчман Г.И. (1996) Антиоксидантная защита отобранных in vivo высоко- и низкозлокачественных вариантов опухолевых клеток сирийского хомяка. ДАН, 351, 5,
- Ключарева Т.Е., Матвеева В. А. (1983) Характеристика нормальных киллеров (НК-клеток) и особенности цитотоксического теста у сирийских хомяков. БЭБиМ, XCVI, 10, 86−88
- Ключарева Т.Е., Матвеева В. А. (1985) Характеристика НК-клеток у сирийских хомяков носителей опухолей с различной метастатической и резистентность подавляющей активностью. БЭБ и М, XCIX, 6, 732−734
- Ключарева Т.Е., Матвеева В. А. (1987) Способ определения способности клеток секретировать простагландин Е в среду культивирования. Авторское свидетельство № 1 529 125
- Ключарева Т.Е., Матвеева В. А. и Уварова Э.Н. (1990) Чувствительность опухолевых клеток к цитостатическому действию НК-клеток и их способность к выбросу простагландинов E-типа. БЭБ и М, 9, 308−310
- Ключарева Т.Е., Матвеева В. А., Бассалык A.C. и Кушлинский Н.Е. (1988) Секреция простагландинов типа Е (ill Е) опухолевыми клетками сирийского хомяка при их контакте in vitro с естественными кипллерами. БЭБ и М, CV, 2, 204−205
- Лавникова Н.А., Бурделя Л. Г. (1990) Чувствительность клеток различной степени злокачественности к цитотоксическому действию резидентных перитонеальных макрофагов сирийских хомяков. БЭБ и М, 7, 83−85
- Матвеева В.А. (2001) Выброс простагландина Е2 опухолевыми клетками человека и сирийского хомяка и их чувствительность к цитостатической активности естественных киллеров. БЭБ иМ, 131,2, 191−194
- Матвеева В.А., Ключарева Т. Е. и Уварова Э.Н. (1993) Динамика секреции и ингибиции простагландинов Е (ПГЕ) в опухолевых клетках при их контакте с НК-клетками in vitro. БЭБ и М, 2, 193−194
- Пирогов А.В., Аббасова С. Г., Дьякова Н. А., Кушлинский Н. Е. и Дейчман Г.И. (2002) Изменения в соотношении мембраносвязанной и растворимой форм CD95 (Fas) при отборе опухолевых клеток in vivo. Биохимия, 67 (2), 286−292
- Adams DO, Johnson WJ and Marino PA (1982) Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity. Fed. Proc., 41, 22 122 221
- Adams DO, Nathan CF (1983) Molecular mechanisms in tumor-cell killing by activated macrophages. Immunology Today 4: 165−170
- Aebi H (1984) In: Methods of Enzymatic Analysis 2, 673−684
- Alexander P (1977) Innate host resistance to malignant cells not involving specific immunity. In: SB Day et. al (eds), Cancer Invasion and metasis: biological mechanisms and therapy, 259−275. Raven press, NY
- Alexander P, Eccles S (1984) Host-mediated mechanisms in the elimination of circulating cancer cells. In: Cancer Invasion and Metastasis: Biological and
- Therapentic Aspects. G.L. Nicolson and L. Milas (Eds). Raven Press N.Y. pp.293 308
- Alstrom CG (1964) Neoplasms in mammals induced by Rous chiken sarcoma material. Natl. Cancer Inst. Monograph, 17,299−317
- Alterman AL, Fornabaio DM and Stackpole CW (1985) Metastatic dissemination of B16 melanoma: pattern and sequence of metastasis. J. Natl. Cancer Inst., 75, 691−702
- Amber IJ, Hibbs JB, Taintor RR and Vavrin Z (1988) Cytokines induce an L-arginine-dependent effector system in nonmacrophage cells. J. Leukoc. Biol., 44, 58−65
- Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res., 52, 1399−1405.
- Balaban GB, Herlyn M, Clark WH and Nowell PC (1986) Karyotypic evolution in human malignant melanoma. Cancer Genet Cytogenet. 19(1−2): 113−22.
- Bishop JM (1991) Molecular themes in oncogenesis. Cell.64(2):235−48
- Boon T, Cerrottini J-C, Van den Eynde B, Van den Bruggen P and Van Pel A (1994) Tumor antigens recognized by T lymphocytes Ann. Rev. Immunol., 12, 337−365
- Brunda MJ, Herberman RB and Holden H.T. (1980) Inhibition of murine natural killer cell activity by prostaglandins. J.Immunol., 124,2682−2687
- Burdelya LG (1997) Growth-regulating influence of non-activated resident macrophages on transformed and tumor cells in the in vitro contact interactions. Neoplasma, 44, 1, 31−35
- Burdelya LG, Grosheva IA, Dyakova NA and Deichman GI (1998) Nonactivated macrophage-induced nitric oxide production by tumor cells differing in tumorigenic and spontaneous metastatic activities. Tumor Biology, 19, 5, 346−355
- Cascino I, Fiucci G, Papoff G and Ruberti G. (1995) Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol., 154, 2706−2713.
- Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ and Mountz JD (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule Science, 263, 1759−1762.
- Cifone MA, Fidler IJ (1981) Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. PNAS, 78, 11,6949−6952
- Deichman GI (1983) Host natural resistance and experimental carcinogenesis. В кн. «Modulators of experimental carcinogenesis». IACR, Lyon, Eds. Turusov V. and Montesano R., 113−122
- Deichman GI (1988) Natural host resistance and in vivo selection of malignant tumor cells. Cancer Surveys, 7, 4, 675−690
- Deichman GI (2002) Early phenotypic changes of in vitro transformed cells during in vivo progression: possible role of the host innate immunity. В кн. «Seminars of Cancer Biology», Academic Press (в печати)
- Deichman GI, Matveeva VA, Kashkina LM, Dyakova NA, Uvarova EN, Nikiforov MA and Gudkov AV (1998) Cell transforming genes and tumor progression: in vivo unified phenotypic secondary cell changes. Int.J.Cancer, 75, 2, 277−283
- Deichman GI, Vendrov EL (1986) Characteristics of in vitro transformed cells essential for their in vivo survival, selection and metastasizing activity. Int. J. Cancer, 37, 401−409
- DePinho RA (2000) The age of cancer. Nature, 408, 248−254.
- Droller M, Schneider M and Perlman P. (1979) A possible role of prostaglandins in the inhibition of natural and antibody dependent cell-mediated cytotoxicity against tumor cells. Cell Immunol., 39, 165−177
- Dyson N, Bulkovich K, Whyte P and Harlow E (1989) Cellular proteins that are targetted by DNA tumor viruses for transformation. Princess Takamatsu Symp., 20, 191−198
- Fearon ER, Volgenstein B (1990) A genetic model for colorectal tumorigenesis. Cell. 61, 5, 759−767
- Fidler IJ (1970) Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with I-5-Iodo-2'-deoxyuridine. J. Natl. Cancer Inst., 45, 773−782.
- Fidler IJ (1978) Tumor Heterogeneity and the Biology of Cancer Invasion and Metastasis. Cancer Res., 38, 2651−2660
- Fidler IJ (1990) Critical factors in the biology of human cancer metastasis: twenty-eighth GHA Clowes memorial award lecture. Cancer Res., 50, 6130−6138.
- Fidler IJ, Kripke ML (1977) Metastasis results from preexisting variant cells within a malignant tumor. Science, 197, 4306, 893−895
- Fidler IJ, Poste G (1982) Macrophage-mediated destruction of malignant tumor cells and new strategues for the therapy of metastatic disease. Spr. Sem Immun., 5, 161−174
- Fischel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, Kane M and Kolodner R (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75, 1027−1038.
- Flint J, Shenk T (1997) Viral transactivating proteins. Annu Rev Genet., 31, 177 212
- Foulds L (1954) Tumor progression. Cancer Res., 17, 355−356.
- Fulton AM (1984) Effects of indomethacin on the growth of cultured mammary tumors Int.J.Cancer, 33, 375−379
- Glaves D (1983) Correlation between circulating cancer cells and incidence of metastases. Br. J. Cancer, 48, 665−673.
- Glaves D (1986) Intravascular death of disseminated cancer cells mediated by superoxide anion. Inv. Metast., 6, 101−111
- Gorelik E, Feldman M and Segal S (1982) Selection of 3LL tumor subline resistant to natural effectors cells concomitantly selected for increased metastatic potency Cancer Immunol, and Immunother., 12, 105−109
- Gronberg A, Kisseling R, Ericksson E and Hannson M (1981) Variants from a MLV-induced lymphoma selected for decreased sensitivity to NK lysis. J. Immunol, 127, 1734−1739
- Hahn WC, Counter CM, Lundberg AS, Behersbgarn RL, Brooks MW and Wamberg RA (1999) Creation of human tumor cells with defined genetic elements. Nature, 400, 464−468.
- Hamilton TA, Adams DO (1987) Molecular mechanisms of signal transduction in macrophages. Immunol. Today, 8, 151−158
- Hanahan D, Weinberg RA (2000) The Hallmarks of Cancer. Cell, 100, 57−70
- Hanna N (1982) Role of natural killer cells in control of cancer metastasis. Cane. Metast. Rev., 1, 45−64
- Hanna N, Burton RC (1981) Definite evidence that natural killer (NK) cells inhibit experimental tumor metastasis in vivo. J. Immunol, 127, 1754−1758
- Hart IR, Fidler IJ (1980) Cancer invasion and metastasis. Q Rev Biol., 55, 2, 121 142
- Hooper ML (1998) Tumour suppressor gene mutations in humans and mice: parallels and contrasts. EMBO J., 17, 23, 6783−6789
- Hoppe-Seyler F, Butz K (1995) Molecular mechanisms of virus-induced carcinogenesis: the interaction of viral factors with cellular tumor suppressor proteins. J Mol Med., 73, 11, 529−538
- Hunter T (1997) Oncoprotein networks. Cell, 88, 3, 333−346
- Kanner SB, Parsons SJ, Parsons JT and Gilmer TM (1988) Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells. Oncogene, 2, 327−335
- Kinzler K, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159−170.
- Kirsh R, Poste G (1986) Macrophage-mediated tumor cell destruaction: opportunities for treatment of metastatic disease. In: CM Chadwick (ed), Receptors in tumor biology, 34−57 Cambrige Univer. Press, Canbrige
- Klein E (1955) Gradual transformation of solid into ascites tumors. Evidence favouring mutation-selection theory. Exp. Cell Res., 8, 188−212
- Klein E, Mantovani A (1993) Action of natural killer cells and macrophages in cancer. Current Opinion in Immunology, 5, 714−718
- Klein G (1998) Foulds' dangerous idea revisited: the multistep development of tumors 40 years later. Adv Cancer Res., 72, 1−23
- Klein G, Klein E (1985) Evolution of tumours and the impact of molecular oncology. Nature, 315, 6016, 190−195
- Kluchareva TE, Matveeva VA and Kushlinsky NE (1992) In vitro bioassay for type E prostaglandins based on their NK immunodepressing activity. Imm. Lett., 33, 3, 239−246
- Koch FE (1939) Krebsforsch., 48, 495−505
- Levine AJ (1993) The tumor suppressor genes. Annu Rev Biochem., 62, 623−651
- Liotta LA, Kleinerman J and Saidel GM (1974) Quantitative relationships of intravascular tumor cells, tumor vessels and pulmonary metastases following tumor implantation. Cancer Res., 34, 997−1004.
- Loeb LA (2001) A mutator phenotype in cancer. Cancer Res., 61, 3230−3239.
- Nathan CF, Arrick BA, Murray HW, De Santis NM and Cohn ZA (1981) Tumor cell antioxidant defences. Inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysis. J.Exp.Med., 153, 766−782
- Nathan CF, Cohn ZA (1981) Antitumor effects of hydrogen peroxide in vivo. J. Exp. Med., 154, 1539−1553
- Nathan CF, Silverstein SC, Brukner LH, Cohn ZA (1979) Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J.Exp.Med., 149, 100−113
- Naylor SL, Johnson BE, Minna JD, Sakaguchi AY (1987) Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature, 329, 6138, 451−454
- Nicolson GL (1984) Generation of phenotypic diversity and progression in metastatic tumor cells. Cancer Metastasis Rev., 3, 1, 25−42
- Nicolson GL (1988) Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta, 948, 2, 175−224
- Nolibe D, Popupon MF (1986) Enhancement of pulmonary metastases induced by decrease lung natural killer cell activity. JNCI, 77, 99−103
- Old LJ (1981) Cancer immunology: the search for specificity~G. H. A. Clowes Memorial lecture. Cancer Research, 47, 261−275
- Patek PO, Lin Y, Collins JL and Cohn M (1986) In vivo or in vitro selection for resistance to natural cytotoxic cell lysis selected for variants with increased tumorigenicity. J.Immunol., 136, 741−745
- Plescia OJ, Smith AH and Grenwich K (1975) Subversion of the immune system by tumor cells and the role of prostaglandins. PNAS, 72, 1848−1851
- Poste G, Fidler IJ (1980) The pathogenesis of cancer metastasis. Nature, 2o3, 5743, 139−146
- Poste G, Greig R (1982) On the genesis and regulation of cellular heterogeneity in malignant tumors. Invasion Metastasis, 2, 3, 137−176.
- Price JE, Aukerman SL and Fidler IJ (1986) Evidence that the process of murine melanoma metastasis is sequental and selective and contains stochastic elements. Cancer Res., 46, 5172−5178.
- Price JE, Carr D and Tarin D (1981) Spontaneous and induced metastasis of naturally occuring tumors in mice: analysis of cell shedding into the blood. J. Natl. Cancer Inst., 73, 1319−1326.
- Renan MJ. (1993) How many mutations are required for tumorigenesis Implication from human cancer data. Mol. Carcinogenesis, 7,139−146.
- Riccardi C, Puccetti P, Santoni A and Herberman RB (1979) Rapid in vivo assay of mouse natural killer cell activity. J Natl Cancer Inst., 63, 4, 1041−1045
- Riccardi C, Santoni A, Barlozzari T, Puccetti P and Herberman RB. (1980) In vivo natural reactivity of mice against tumor cells. Int J Cancer, 15, 25,4, 475−486
- Scarpa A, Tognon M (1998) Molecular approach in human tumor investigation: oncogenes, tumor suppressor genes and DNA tumor polyomaviruses (review). Int J Mol Med., 1,6, 1011−1023.
- Schrieber H (1993) Tumor immunology. In: Fundamental Immunology. Third Edition. W.E. Paul (Editor). Raven Press, N.Y. 1143−1178
- Schroter M, Peli J, Hahne M, Tschopp J and Reichmann E (2000) Fas-dependent tissue turnover is implicated in tumor cell clearance. Oncogene, 19, 1794- 1800.
- Schultz RM, Pavlidis NA, Stylos WA and Chirigos MA (1978) Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series. Science, 202, 4365,320−321.
- Sniderman R, Pike MC (1976) An inhibitor of macrophage chemotaxix produced by neoplasms. Science, 192, 370−372
- Stackpole CW (1981) Distinct lung-colonizing and lung-metastasizing cell populations in B16 mouse melanoma. Nature (Lond.), 289, 798−800.
- Sugden B (1993) How some retroviruses got their oncogenes. Trends Biochem Sei., 18, 7, 233−235
- Svoboda J (1964) Malignant interaction of Rous virus with mammalian cells in vivo and in vitro. Natl. Cancer Inst. Monograph, 17, 277−298
- Talmadge JE and Fidler IJ (1982) Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J Natl Cancer Inst., 69,4, 975−980
- Varmus H (1984) The molecular genetics of cellular oncogenes. Annual Rev. Genet., 18, 553−612
- Volpe EA (1992) Acquisition of a malignant phenotype by low-malignant STHE hamster cells: in vitro selection by activated macrophages. J.Exp.Clin.Cancer Res., 11, 2, 109−122
- Walker PR, Saas P and Dietrich P-Y (1997) Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back. J.Immun., 158, 4521−4524
- Weinberg RA (1995) The molecular basis of oncogenes and tumor suppressor genes. Ann N Y Acad Sci., 758, 331−338
- Wexler H, Ryan JJ and Ketcham AS (1969) The study of circulating tumor cells by the formation of pulmonary embolic tumor growths in a secondary host. Cancer, 23,946−951
- Yamashina K, Fulton A and Heppner G (1985) Differential sensitivity of metastatic versus nonmetastatic mammary tumor cells to macrophage-mediated cytostasis. J. Natl. Cancer Inst., 75, 765−770
- Yokuta J (2000) Tumor progression and metastasis. Carcinogenesis, 21, 497 503.
- Young R, Knies S (1984) Prostaglandin E production by Lewis lung carcinoma: mechanisms for tumor establishment in vivo. J. Natl. Cancer Inst., 72, 919−922